Our Stocks to Watch today include SpongeTech Delivery Systems, Inc. (OTCBB: SPNG), ReelTime Rentals, Inc. (OTC: RLTR), Smart Chip Technologies (OTC: SCTN), Acura Pharmaceuticals, Inc. (OTCBB: ACPH), Labopharm Inc. (NASD: DDSS), Canadian Blue Gold Inc. (OTC: CBGC)
Visit http://www.otcpicks.com/ to register for our Daily Market Mover’s Digest Newsletter, and Email Stock Watch Alerts.
SPONGETECH DELIVERY SYSTEMS (OTCBB: SPNG)
Detailed Quote: http://www.otcpicks.com/quotes/SPNG.php
Company Profile: http://www.otcpicks.com/spongetech/spongetech.htm
SpongeTech Delivery Systems is a development stage company which designs, produces, markets and distributes cleaning products for vehicular use utilizing patented technology relating to sponges containing hydrophilic (liquid absorbing) foam polyurethane matrices. The Company's sponges are specially configured with an outer contact layer and an inner matrix, which is loaded with specially formulated soaps and wax that are released when the sponge is applied to a surface with minimal pressure. The Company's products are currently designed specifically for vehicular cleaning use. However, the Company is exploring the possibility of using its patented technology for the development of sponges for other uses, including for use with anti-bacterial, bath and kitchen soaps for household uses, as well as for use as a children's bath foam sponge.
SPNG News:
January 31 - SA Trading LLC Places Order for SpongeTech's New 'Pet Sponge'
SpongeTech Delivery Systems, Inc. (OTCBB: SPNG) announced that SA Trading LLC will be distributing the SpongeTech(R) Pet Sponge, a new pet care product, the "Pet Sponge," to its' family of products based on the SpongeTech Delivery System technology. The new Pet Sponge product is made with a mild, no-tear, soap formula. The soap also contains a pet hair conditioner, a pet fur luster and sheen additive and an odor neutralizer. Like other SpongeTech products, the Pet Sponge is made of 100% Hydrophilic Foam and is 99.8% bacteria free. The germs can't get in, but the soap can get out. The new SpongeTech Pet Sponge can be used for up to 8 pet washes and is safe for both dogs and cats.
SA Trading LLC has ordered the complete pet package with the SpongeTech(R) Pet Chamois, assuring you the best results by completing the process of drying your pet. This is included as part of the SA Trading LLC Pet Sponge package! The SpongeTech(R) Pet Chamois is super absorbent and holds up to 100 times its' weight in water, yet remains soft and flexible, even after it dries out!
SpongeTech's COO Steven Moskowitz commented, "SpongeTech is very happy to be able to announce the new Pet Sponge product. As we have stated in the last few months, we have plans for new products in completely new market segments utilizing our core SpongeTech Delivery Systems technology. The new SpongeTech Pet Sponge and Pet products is an excellent example of the adaptation of our core sponge technology to bring new products to market. We are excited about the new SpongeTech Pet Sponge and Pet Chamois products as they will allow us to gain entry into the multi-billion dollar pet care market and will open up new sales, marketing and distribution opportunities for SpongeTech. We already have one sizeable Pet Sponge product order on the books and we will be ramping up production for this product in the very near future. With support from companies like SA Trading, we should add significant new incremental revenues for our company in 2008 and beyond."
For more information, contact 1-877-SPONGE T or visit the company website at www.spongetech.com/newproducts.htm
REELTIME RENTALS INCORPORATED (OTC: RLTR)
Detailed Quote: http://www.otcpicks.com/quotes/RLTR.php
Company Profile:
http://www.otcpicks.com/reeltime-rentals/reeltime-rentals.htm
ReelTime Rentals Inc. (sometimes referred to herein as RLTR or ReelTime.com) was incorporated under the corporate laws of the state of Washington as ReelTime Rentals; Inc on June 24, 2004. ReelTime.com is an online broadband network offering a diverse library of both theatrical films and television programming. ReelTime's "point click and watch" user interface delivers DVD quality video over the internet to customers nationwide whenever they want to see it. ReelTime is poised to change the home entertainment industry by becoming a leader in the online media marketplace, providing the public the next generation of online viewing technology with built-in capacity for unlimited growth. The company's Intelligent Rapid Delivery System (IRDS) overcomes many of the roadblocks that have previously prevented widespread adoption of high quality streaming video. Through IRDS and their video-on-demand services, they deliver full-screen DVD quality movie experiences to broadband customers nationwide while implementing security measures to combat the threat of piracy.
The company currently provides direct-to-desktop progressive downloading for broadband users, utilizing a proprietary player to deliver full length films and television shows for viewing by the next generation of media viewers. We strongly believe in ReelTimes future and see unlimited potential beyond the PC into other media platforms, including set top boxes and handheld devices. ReelTime's end-to-end delivery system (IRDS) has significant advantages in cost and structure over other systems in current use and the revolutionary nature of the system should allow ReelTime to quickly become a dominant player in the video-on-demand marketplace.
RLTR News:
January 31 - ReelTime Reaches Redistribution Agreements
ReelTime Rentals, Inc. (OTC: RLTR) announced that it has agreements with several of its content providers, including television programming and top-tier full length feature films, to utilize ReelTime's Intelligent Rapid Delivery System (IRDS) solution for redistribution of media content. This will allow other online video providers to have access to a variety of content currently licensed by ReelTime, providing they employ the IRDS platform on their websites.
In the dynamic and cutting-edge industry of online video distribution, IRDS has been widely accepted by both content providers and major studios for its superior user experience, excellent visual quality, and impenetrable piracy protection. ReelTime's ongoing content acquisition coupled with the leveraging of its licensing agreements will provide additional income and establish an updated business model for the Company.
"Licensing of content has historically been an expensive and time-consuming obstacle for ReelTime. The delivery of DVD-quality video has also shown its own different set of challenges. ReelTime is now able to leverage its ability to accomplish both of these things in a way that opens doors for other business opportunities. We are very excited about the revenue stream to come from redistribution, and are honored by the exclusivity of this agreement with our content providers," said Barry Henthorn, ReelTime's CEO.
SMART CHIP TECHNOLOGIES (OTC: SCTN)
"Up 31.25% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/SCTN.php
Smart Chip Technologies' turnkey customer retention solutions, including Loyalty, Pre-Paid Stored Value, Punch Cards, and Gift Cards, enable issuers, acquirers, and merchants to take advantage of real-time programs using their cardholders' existing cards using bar codes, magnetic stripes, smart chips, RFID, Internet accounts, and other consumer electronic devices. The SCTN system is a scalable, high performance, end-to-end solution that uses an ASP model to customize the system's look and feel to reinforce customer branding.
SCTN News:
February 1 - SCTN Files 2003K With SEC
Smart Chip Technologies (OTC: SCTN) announced that the company has filed its 2003 10k with the SEC.
Forms 10K from 2004 through 2007 will also be filed shortly thereafter. Completing the filings will allow the company to move forward to the Over the Counter Bulletin Board (OTCBB) market once the SEC approves their filings.
The company believes that these filings will increase and enhance the company value for shareholders, potential investors, creditors, partners and customers as well as allowing for additional exposure with brokerage houses that will result in increased volume and liquidity for the company stock in the marketplace.
Major License sales and revenue contracts are moving closer and closer to the finalization process and several are expected to close within the next few months.
"We would like to thank our shareholders for their continued support and patience. It has been a long difficult road but the company is now beginning to achieve significant progress in reaching and accomplishing its objectives in Year 2008," stated Bernard McHale, Director of Smart Chip Technologies.
ACURA PHARMACEUTICALS (OTCBB: ACPH)
"Up 24.62% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/ACPH.php
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of abuse deterrent, abuse resistant, and tamper resistant formulations intended for use in orally administered pharmaceutical products. It develops products based on its Aversion Technology, which is applicable to immediate release and extended release, orally administered tablets and capsules, and can be formulated into orally administered tablets or capsules containing commonly utilized opioid active pharmaceutical ingredients or other potentially abuseable drugs. The company's lead product candidate includes OxyADF tablets, which are in various stages of clinical trials, incorporates the Aversion Technology with oxycodone HCl as the active analgesic ingredient in an immediate release tablet intended for oral administration. In addition, it engages in the formulation development of additional immediate release product candidates intended for oral administration incorporating Aversion Technology, including hydrocodone bitartrate with acetaminophen tablets, hydromorphone HCl tablets, and Oxycodone HCl with acetaminophen. The company was founded in 1935 and is based in Palatine, Illinois.
ACPH News:
January 31 - Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
Acura Pharmaceuticals, Inc. (OTCBB: ACPH) announced that The NASDAQ Stock Market® has approved the Company's application to list its common stock on the NASDAQ Capital Market® ("NASDAQ"). The Company's common stock will commence trading on NASDAQ on February 4, 2008 under the trading symbol "ACUR".
"We are pleased to join the growing list of specialty pharmaceutical companies trading on NASDAQ," stated Andy Reddick, the Company's CEO. "We believe that our new NASDAQ listing will provide enhanced liquidity and visibility and we are looking forward to attracting research analyst coverage as a result of our listing."
LABOPHARM INCORPORATED (NASD: DDSS)
"Up 18.97% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/DDSS.php
Labopharm, Inc., a specialty pharmaceutical company, develops drugs by incorporating its proprietary controlled-release technologies. It offers a once-daily formulation of the pain-killer, tramadol to treat patients with moderate to severe pain in the United States, Europe, Mexico, Latin America, and the Caribbean. The company conducts Phase III clinical studies for once-daily formulations of Trazodone, an antidepressant; Phase I clinical studies for Tramadol combination products to meter the dispersion of two active ingredients for clinically beneficial interaction between the drugs; Phase I clinical studies for abuse resistant formulations of an opioid drug to provide patient safety; and Phase I clinical studies for anti-inflammatory products. It also develops a once-daily formulation of betahistine, an oral histamine analogue, for the treatment of the symptoms related to Meniere's disease, a disorder characterized by recurrent vertigo and hearing loss; and DDS-2001, an undisclosed formulation in Phase I studies. Labopharm's products are based on Contramid platform, a drug delivery technology that meters the release of drugs from orally administered solid dosage forms, such as tablets. In addition, it develops polymeric nano-delivery systems for delivery of water-insoluble and poorly bio-available drugs, as well as for developing intravenous and oral formulation product candidates. The company was founded in 1990. It was formerly known as Centre de recherche appliquee pharmaceutique CRAP, inc. and changed its name to Labopharm, Inc. in 1994. Labopharm, Inc. is headquartered in Laval, Canada.
DDSS News:
February 1 - Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly
Labopharm's Canadian Marketing Partner, Paladin, Enters Into Co-Promotion Agreement with Nycomed Canada
Labopharm Inc. (NASD: DDSS) (TSX: DDS) announced that its Canadian licensing and distribution partner for its once-daily tramadol product (Tridural(TM)), Paladin Labs Inc. (TSX: PLB), has entered into a co-promotion agreement for Tridural(TM) with Nycomed Canada Inc. The agreement will double the number of primary care sales representatives promoting Tridural(TM) in Canada.
"The addition of Nycomed's sales force to that of Paladin will significantly expand the marketing and sales effort behind our product," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. "We are very pleased with the continued penetration of Tridural(TM) into the Canadian pain market. While still relatively early in the launch, growth indicators and feedback from the market are very strong."
Under the co-promotion agreement between Paladin and Nycomed, Nycomed will share brand responsibilities and expenses with Paladin and will deploy a national primary care sales force to promote Tridural(TM). Paladin will continue to manage distribution of Tridural(TM) and will also continue to promote Tridural(TM) using its primary care sales force.
Labopharm entered into a licensing and distribution agreement for its once-daily tramadol product for Canada with Paladin in July 2007. Paladin subsequently launched the product to the Canadian market in September 2007.
ABOUT TRIDURAL™
Tridural(TM) is a unique treatment option developed as a first-line therapy for adult patients with moderate pain who require treatment for several days or more that provides 24-hour pain relief from a single tablet taken once-daily. Tridural(TM) is based on Labopharm's proprietary controlled-release technology, Contramid®, and a novel dual matrix delivery system that facilitates both rapid and sustained drug release, maintaining therapeutic blood levels of tramadol for a full 24-hour period. Tridural(TM) offers physicians and patients greater treatment flexibility based on its relatively rapid two-day titration schedule, which could help patients reach their optimum daily dose faster than any other approved once-daily tramadol product and quickly achieve effective pain relief. In addition, Tridural(TM) has a demonstrated safety profile based on clinical trial experience of more than 2,400 patients globally and almost two years of commercial experience.
CANADIAN BLUE GOLD (OTC: CBGC)
"Up 150.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/CBGC.php
Canadian Blue gold bottles and sells water sourced from Northern Quebec springs in Canada and other exclusive healthy beverages. The company has offices in Los Angeles, California, Orlando, Florida and Montreal, Canada.
CBGC News:
February 1 - Canadian Blue Gold Finalizes Merger Agreement With a North American Water Bottling Company
Company Was in Quiet Period During Due Diligence Process
Canadian Blue Gold Inc. (OTC: CBGC) announced that it has finalized a Merger Agreement with a leader of the North American water bottling industry. Canadian Blue Gold Management indicated that the Merging Company is well established in the water distribution market both in Canada and the United States.
Canadian Blue Gold will disclose further information regarding the transaction upon consent from the respective attorneys and approval by applicable regulatory authorities.
For more information on Canadian Blue Gold, visit the company's corporate Web site at http://www.canadianbluegold.com/ and/or contact Canadian Blue Gold's Investor Relations firm Equiti-trend Advisors. Representatives are available on market days from 9:30 a.m. to 5:30 p.m. EST by calling (800) 953-3350.
ABOUT OTCPICKS.COM
OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover’s Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Disclaimer:
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The OTCPicks.com employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.
Release of Liability:
Through use of this website viewing or using you agree to hold OTCPicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. OTCPicks.com has been compensated six thousand dollars and one hundred twenty five thousand free trading shares by a third party for RLTR advertising and promotional services. OTCPicks.com has been compensated seventeen thousand dollars by the company and four hundred thousand free trading shares by a non-controlling third party for multiple 30-day SPNG IR programs. For a complete list of disclosures go to http://www.otcpicks.com/disclosure_details.php. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCPicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCPicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTCPicks.com and its affiliates are not registered investment advisors or a broker dealers. OTCPicks.com has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor’s sole risk. OTCPicks.com also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTCPicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through OTCPicks.com. OTCPicks.com owners may or may not hold positions in the companies that are profiled.
The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.
Third Party Web Sites and Information:
